Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01868334 · ClinicalTrials.gov registry record · NA
SOP Toolkit in Diverse Practices Implemented & Tested With RE-AIM
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 70,549
- Enrollment target
NCT01868334 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 70,549 participants.
The verdict
NCT01868334, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 70,549 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether or not the 4 Pillars Toolkit increases adult Influenza, pneumococcal polysaccharide vaccine (PPSV), tetanus, adult diphtheria and acellular pertussis vaccine (Tdap/Td) vaccination rates. The vaccines are all FDA licensed vaccines and to be used according to national guidelines. The investigators will conduct a randomized cluster trial of this toolkit in diverse primary care practice with electronic medical records (EMRs).
Interventions
- BEHAVIORAL Pillar 1: Convenient Vaccination Services
- BEHAVIORAL Pillar 2: Patient notification
- BEHAVIORAL Pillar 3: Enhanced Office Systems
- BEHAVIORAL Pillar 4: Motivation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70,549 participants |
| Start Date | 2013-04 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01868334
The ClinicalTrials.gov registry entry for NCT01868334 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70,549 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Pillar 1: Convenient Vaccination Services is the first listed.
NCT01868334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01868334 about?
NCT01868334 is a clinical study titled "SOP Toolkit in Diverse Practices Implemented & Tested With RE-AIM". The purpose of this study is to test whether or not the 4 Pillars Toolkit increases adult Influenza, pneumococcal polysaccharide vaccine (PPSV), tetanus, adult diphtheria and acellular pertussis vaccine (Tdap/Td) vaccination rates. The vaccines are all FDA licensed vaccines and to be used according ...
What is the current status of trial NCT01868334?
This trial is currently completed. It is a NA study. The enrollment target is 70,549 participants. The study started on 2013-04. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01868334?
The interventions under investigation include: Pillar 1: Convenient Vaccination Services (BEHAVIORAL), Pillar 2: Patient notification (BEHAVIORAL), Pillar 3: Enhanced Office Systems (BEHAVIORAL), Pillar 4: Motivation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01868334?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.